Senorx, Inc.: FDA filings under this applicant name
FDA lists 30 510(k) clearances under the applicant name “Senorx, Inc.” (first 2000, latest 2023), across 7 product codes in 2 review panels. Median 510(k) review time under this name: 22 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 0 | — |
| 2013 | 1 | 21 |
| 2014 | 0 | — |
| 2015 | 0 | — |
| 2016 | 1 | 18 |
| 2017 | 0 | — |
| 2018 | 0 | — |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 1 | 27 |
| 2022 | 0 | — |
| 2023 | 1 | 29 |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Senorx, Inc. took a median 28 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 117 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| KNW | Instrument, Biopsy | 9 | 9 |
| NEU | Marker, Radiographic, Implantable | 7 | 7 |
| GEI | Electrosurgical, Cutting & Coagulation & Accessories | 6 | 6 |
| JAQ | System, Applicator, Radionuclide, Remote-Controlled | 5 | 5 |
| FZP | Clip, Implantable | 1 | 1 |
| GDW | Staple, Implantable | 1 | 1 |
| ITX | Transducer, Ultrasonic, Diagnostic | 1 | 1 |
Review panels
- General and Plastic Surgery (24)
- Radiology (6)
Most recent Senorx, Inc. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K233220 | EnCor EnspireBreast Biopsy System (E4115, E4230); EnCor Breast Biopsy Driver (DRENCOR); EnCor MRI Breast Biopsy Driver (DRENCORMR); EnCor Breast Biopsy Driver Probes (ECP017G, ECP017GV, ECP0110G, ECP0110GV, ECP0112G, ECP0112GV); EnCor MRI Breast Biopsy Probes (ECPMR017G, ECPMR0110G, ECPMR0110GBT) | KNW | 2023-10-27 | 29 |
| K210654 | EnCor Breast Biopsy Probe with Rinse Tube | KNW | 2021-03-31 | 27 |
| K161805 | EnCor MRI Introducer Set, EnCor Probe Introducer | KNW | 2016-07-19 | 18 |
| K131654 | STARCHMARK BREAST TISSUE MARKER; STARCHMARK ULTRACOR BREAST TISSUE MARKER | NEU | 2013-06-27 | 21 |
| K093512 | ENCOR BREAST BIOPSY SYSTEM | KNW | 2009-11-20 | 7 |
| K092323 | CONTURA CAVITY MAINTENANCE CATHETER | JAQ | 2009-08-19 | 15 |
| K082264 | CONTURA LUMEN MARKER | JAQ | 2008-09-12 | 32 |
| K081085 | STARCHMARK BIOPSY SITE MARKER, MODEL STMKEC-10GSS, STMKEC-10GTR, STMKMT-11GS | NEU | 2008-08-01 | 107 |
| K081170 | PROSTATE TISSUE MARKER | NEU | 2008-05-28 | 34 |
| K081079 | CONTURA MLB SOURCE APPLICATOR FOR BRACHYTHERAPY | JAQ | 2008-05-02 | 16 |
20 earlier clearances. See the full list in Caduvo.
Recalls
FDA recall records list no recalls under a recalling firm named Senorx, Inc..
10 product recalls in 2 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 0 initiated in the last five years. Most often: Bard Peripheral Vascular Inc (10).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
An industry sponsor named Senorx, Inc. is the lead sponsor of 2 device studies on ClinicalTrials.gov (0 active or recruiting). Most recent:
- NCT01072838: Safety Study for Short-course Accelerated, Hypofractionated Partial Breast Radiotherapy (APBI) in Women With Early Stage Breast Cancer Using the Contura MLB (Terminated, started 2009-12)
- NCT00699101: Using the Conture® Multi-Lumen Balloon to Deliver Accelerated Partial Breast Brachytherapy (Terminated, started 2008-06)
Frequently asked questions
How many FDA 510(k) clearances are listed under Senorx, Inc.?
FDA lists 30 510(k) clearances under the applicant name “Senorx, Inc.” (first 2000, latest 2023), across 7 product codes in 2 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Senorx, Inc.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Senorx, Inc. is 22 days.
Which FDA product codes appear under Senorx, Inc.?
The most frequent FDA product codes under this applicant name are KNW (Instrument, Biopsy, 9); NEU (Marker, Radiographic, Implantable, 7); GEI (Electrosurgical, Cutting & Coagulation & Accessories, 6).
Next steps
- See all 30 Senorx, Inc. clearances with predicates and recalls
- Run predicate analysis for product code KNW, Senorx, Inc.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.